Methylphenidate - Appraisement of Clinical Indications and Contraindications
Journal: Medical Journal of Clinical Trials & Case Studies (Vol.4, No. 4)Publication Date: 2020-09-19
Authors : Bianca CV Maria Clara MM Stefanye CM; Mirto NP;
Page : 1-5
Keywords : Methylphenidate; Amphetamine; Attention deficit hyperactivity disorder; Psychological; Subtypes Mild;
Abstract
Introduction: The prescription of methylphenidate still generates controversies regarding the safety and risk. Objectives: To discuss the current use of methylphenidate, being under medical supervision or not. Methods: For this literature review, scientific articles were used as a basis, from sites such as SCIELO, PUBMED in the English and Portuguese languages, from the 1990s to the year 2020. Conclusions: Although some risks with their ingestion are reported, these end up not exceeding the benefits that the drug can provide in the treatment of people are reported with attention deficit and hyperactivity disor
Other Latest Articles
- Expression of Cell Adhesion Molecules in Preeclampsia
- COVID-19 in Al-Najaf Province Iraq until June 2020
- H1N1 Vaccination Beacon of Hope to SARS-COV-2 Infection
- Treatment of Critical, Severe and Non-Severe COVID-19 by Corticosteroids
- Densities, Viscosities and Refractive Indices for Binary and Ternary Mixtures of Dimethylacetamide + Dimethylbenzylamine + Dichloromethane
Last modified: 2023-07-19 14:33:27